|1.||Kohno, Shigeru: 10 articles (01/2012 - 06/2003)|
|2.||Kudoh, Shoji: 9 articles (06/2012 - 01/2002)|
|3.||Kohno, S: 8 articles (05/2007 - 01/2000)|
|4.||Yanagihara, Katsunori: 7 articles (01/2012 - 06/2003)|
|5.||Mukae, Hiroshi: 7 articles (09/2010 - 06/2003)|
|6.||Rubin, Bruce K: 6 articles (01/2014 - 07/2002)|
|7.||Keicho, Naoto: 6 articles (06/2012 - 01/2002)|
|8.||Tomono, Kazunori: 6 articles (11/2006 - 06/2003)|
|9.||Azuma, Arata: 5 articles (01/2012 - 05/2006)|
|10.||Kadota, Jun-ichi: 5 articles (01/2007 - 06/2003)|
|1.||Cystic Fibrosis (Mucoviscidosis)
01/01/2011 - "This use has been well established both in diffuse panbronchiolitis and in cystic fibrosis. "
01/01/2009 - "Prolonged macrolide antibiotic therapy at low doses improves clinical outcome in patients affected with diffuse panbronchiolitis and cystic fibrosis. "
08/01/2008 - "Long-term, low-dose macrolide therapy has been proven to improve survival in patients with diffuse panbronchiolitis and cystic fibrosis, although the mechanisms by which it does so remain unknown. "
05/01/2007 - "Pseudomonas aeruginosa is one of the most important pathogens in patients with chronic airway conditions, such as cystic fibrosis and diffuse panbronchiolitis. "
02/01/2006 - "They are frequently used in the treatment of diffuse panbronchiolitis and cystic fibrosis (CF). "
|2.||Asthma (Bronchial Asthma)
07/01/2002 - "Mucoregulatory agents reduce the volume of airway mucus secretion and appear to be especially effective in hypersecretory states such as bronchorrhea, diffuse panbronchiolitis, and some forms of asthma. "
06/01/2015 - "Single center experience of five diffuse panbronchiolitis patients clinically presenting as severe asthma."
05/01/2010 - "Deterioration of asthma in a patient with diffuse panbronchiolitis (DPB) after macrolide therapy."
12/01/2005 - "Over the past 20 years, chronic inflammatory respiratory conditions, including diffuse panbronchiolitis, cystic fibrosis and asthma have benefited from long-term low-dose macrolide therapy. "
03/01/1998 - "The study population consisted of 294 patients with asthma, chronic obstructive pulmonary disease, diffuse panbronchiolitis and other respiratory systems, and 15 healthy volunteers. "
04/01/2010 - "They have been proven to be beneficial in diffuse panbronchiolitis and are commonly being used in patients with bronchiectasis. "
03/01/1995 - "Purified guinea pig eosinophils were cultured in the presence or absence of sputum extracts, and the eosinophil viability was measured on Day 4. Eosinophil viability in the presence of sputum extracts derived from patients during moderate or severe attacks was significantly higher than that for sputum obtained from patients in remission or during mild attacks or from those with other respiratory diseases, including bronchiectasis and diffuse panbronchiolitis (p < 0.05). "
08/01/1995 - "To study the role of T cells in diffuse panbronchiolitis (DPB), we investigated T-cell subsets in bronchoalveolar lavage fluid (BALF) or 33 patients with DPB, nine patients with bronchiectasis, and 20 healthy volunteers. "
01/01/2015 - "We retrospectively investigated the prevalence of NTM associated with diffuse panbronchiolitis (DPB), a disorder also characterized by reduced mucociliary clearance with bronchiectasis. "
09/01/1997 - "In conclusion, EM therapy for diffuse panbronchiolitis may be stopped if the clinical manifestations of disease (especially purulent sputum) disappear, if diffuse, nodular opacities resolve almost completely and if there is no evidence of bronchiectasis."
01/01/2011 - "Long-term macrolide therapy is an effective treatment for chronic sinusitis and diffuse panbronchiolitis. "
01/01/2005 - "Diffuse panbronchiolitis (DPB) is a progressive inflammatory disease, well recognized in Japan, that is characterized by chronic sinusitis and obstructive small airway disease. "
02/01/1995 - "They also suggest that the patients with chronic sinusitis may be seen as a mild or incomplete type of diffuse panbronchiolitis."
02/01/1995 - "These results indicate that patients with chronic sinusitis only and those with diffuse panbronchiolitis have similar genetic background. "
02/01/1995 - "In the diffuse panbronchiolitis group, 50% of families suffered from chronic sinusitis, in contrast to 18.9% of families in the control group. "
10/01/1978 - "[Clinical and pathological studies on diffuse panbronchiolitis and so-called chronic bronchitis (author's transl)]."
06/01/2004 - "In 1969 the name diffuse panbronchiolitis (DPB) was proposed to distinguish it from chronic bronchitis. "
09/01/1992 - "Diffuse panbronchiolitis (DPB) in Japan is a chronic bronchitis observed in nonsmoking adults, with severe obstruction and poor prognosis. "
11/01/1971 - "[Chronic bronchitis and diffuse panbronchiolitis]."
01/01/2008 - "Low-dose, long-term macrolide therapy has been shown to be effective for the treatment of diffuse panbronchiolitis (DPB) and similar disorders in terms of the presence of airway mucus hypersecretion such as bronchiectasis, chronic bronchitis and sinobronchial syndrome. "
|2.||Anti-Bacterial Agents (Antibiotics)
|5.||Drug Therapy (Chemotherapy)